Inflammation and Cerebral Aneurysms

Translational Stroke Research

Volumn 5, Issue 2, 2014, Pages 190-198

  Hosaka, Koji ^a   Hoh, Brian L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cerebral aneurysm; Cytokine; Hemodynamic stress; Inflammation; Inflammatory cells; Remodeling

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BONE MARROW; BRAIN ARTERY ANEURYSM; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; EMBOLIZATION COIL; ENDOTHELIAL DYSFUNCTION; ENDOVASCULAR ANEURYSM REPAIR; EXTRACELLULAR MATRIX; HEALING; HEMODYNAMIC STRESS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCULAR ANEURYSM; SHEAR STRESS; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

ANIMALS; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTRACRANIAL ANEURYSM;

EID: 84896405199     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0313-y     Document Type: Article

References (125)

1. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain: J Neurol. 2000;123(Pt 2): 205-21.
2. Wiebers DO, Whisnant JP, Huston 3rd J, Meissner I, Brown Jr RD, Piepgras DG, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378): 103-10.
3. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355(9): 928-39.
4. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1): 43-53.
5. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid hemorrhage. Lancet. 2007;369(9558): 306-18.
6. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2, 143 patients with ruptured intracranial aneurysms: a randomized comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488): 809-17.
7. Spetzler RF, McDougall CG, Albuquerque FC, Zabramski JM, Hills NK, Partovi S, et al. The barrow ruptured aneurysm trial: 3-year results. J Neurosurg. 2013;119(1): 146-57.
8. Park SH, Yim MB, Lee CY, Kim E, Son EI. Intracranial fusiform aneurysms: it's pathogenesis, clinical characteristics, and managements. J Korean Neurosurg Soc. 2008;44(3): 116-23.
9. al-Yamany M, Ross IB. Giant fusiform aneurysm of the middle cerebral artery: successful Hunterian ligation without distal bypass. Br J Neurosurg. 1998;12(6): 572-5.
10. Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336(1): 28-40.
11. Shojima M, Oshima M, Takagi K, Torii R, Hayakawa M, Katada K, et al. Magnitude and role of wall shear stress on cerebral aneurysm: computational fluid dynamic study of 20 middle cerebral artery aneurysms. Stroke; J Cereb Circ. 2004;35(11): 2500-5.
12. Jou LD, Lee DH, Morsi H, Mawad ME. Wall shear stress on ruptured and unruptured intracranial aneurysms at the internal carotid artery. AJNR Am J Neuroradiol. 2008;29(9): 1761-7.
13. Castro M, Putman C, Radaelli A, Frangi A, Cebral J. Hemodynamics and rupture of terminal cerebral aneurysms. Acad Radiol. 2009;16(10): 1201-7.
14. Sforza DM, Putman CM, Cebral JR. Hemodynamics of cerebral aneurysms. Ann Rev Fluid Mech. 2009;41: 91-107.
15. Takao H, Murayama Y, Otsuka S, Qian Y, Mohamed A, Masuda S, et al. Hemodynamic differences between unruptured and ruptured intracranial aneurysms during observation. Stroke; J Cereb Circ. 2012;43(5): 1436-9.
16. Hoh BL, Rabinov JD, Pryor JC, Ogilvy CS. A modified technique for using elastase to create saccular aneurysms in animals that histologically and hemodynamically resemble aneurysms in human. Acta Neurochir. 2004;146(7): 705-11.
17. Tada Y, Kanematsu Y, Kanematsu M, Nuki Y, Liang EI, Wada K, et al. A mouse model of intracranial aneurysm: technical considerations. Acta Neurochir Suppl. 2011;111: 31-5.
18. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999;45(5): 1137-46. discussion 1146-1137.
19. Frosen J, Piippo A, Paetau A, Kangasniemi M, Niemela M, Hernesniemi J, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke; J Cereb Circ. 2004;35(10): 2287-93.
20. Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links among inflammation, hemodynamics, and vascular remodeling. Neurol Res. 2006;28(4): 372-80.
21. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Gene expression profile of the intima and media of experimentally induced cerebral aneurysms in rats by laser-microdissection and microarray techniques. Intl J Mol Med. 2008;22(5): 595-603.
22. Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke; J Cereb Circ. 2011;42(1): 173-8.
23. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(5): 969-79.
24. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78(6): 539-52.
25. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol. 1999;72: 7-29.
26. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke; J Cereb Circ. 2009;40(3): 942-51.
27. Andreakos ET, Foxwell BM, Brennan FM, Maini RN, Feldmann M. Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev. 2002;13(4-5): 299-313.
28. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111(2 Suppl): 460-75.
29. Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS, et al. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery. 2005;57(3): 558-64. discussion 558-564.
30. Jayaraman T, Paget A, Shin YS, Li X, Mayer J, Chaudhry H, et al. TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag. 2008;4(4): 805-17.
31. Young AM, Karri SK, You W, Ogilvy CS. Specific TNF-alpha inhibition in cerebral aneurysm formation and subarachnoid hemorrhage. Curr Drug Saf. 2012;7(3): 190-6.
32. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283(5403): 845-8.
33. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Investig. 2000;106(11): 1331-9.
34. Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med. 2002;195(9): 1145-54.
35. Hoh BL, Hosaka K, Downes DP, Nowicki KW, Wilmer EN, Velat GJ, Scott EW: Stromal cell-derived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls. Journal of neurosurgery 2013. doi: 10. 3171/2013. 9. JNS122074.
36. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 1998;10(5): 602-8.
37. Becker LC. Yin and yang of MCP-1. Circ Res. 2005;96(8): 812-4.
38. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75(2): 346-59.
39. Thomson EM, Williams A, Yauk CL, Vincent R. Overexpression of tumor necrosis factor-alpha in the lungs alters immune response, matrix remodeling, and repair and maintenance pathways. Am J Pathol. 2012;180(4): 1413-30.
40. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation. 2009;119(16): 2209-16.
41. Pagano MB, Zhou HF, Ennis TL, Wu X, Lambris JD, Atkinson JP, et al. Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation. 2009;119(13): 1805-13.
42. Cohen JR, Parikh S, Grella L, Sarfati I, Corbie G, Danna D, et al. Role of the neutrophil in abdominal aortic aneurysm development. Cardiovasc Surg. 1993;1(4): 373-6.
43. Rao SK, Reddy KV, Cohen JR. Role of serine proteases in aneurysm development. Ann N Y Acad Sci. 1996;800: 131-7.
44. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias MP, et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation. 2005;112(2): 232-40.
45. Ostergaard JR. Risk factors in intracranial saccular aneurysms. Aspects on the formation and rupture of aneurysms and development of cerebral vasospasm. Acta Neurol Scand. 1989;80(2): 81-98.
46. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes electrolysis in a mouse model of Marfan syndrome. Circ Res. 2001;88(1): 37-43.
47. Sonesson B, Hansen F, Lanne T. Abdominal aortic aneurysm: a general defect in the vasculature with focal manifestations in the abdominal aorta? J Vasc Surg. 1997;26(2): 247-54.
48. Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Aziz HA, Shono M, et al. Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. J Neurosurg. 2007;107(2): 405-11.
49. Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H. Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke; J Cereb Circ. 1998;29(1): 181-8. discussion 189.
50. Sumner DS, Hokanson DE, Strandness Jr DE. Stress-strain characteristics and collagen-elastin content of abdominal aortic aneurysms. Surg Gynecol Obstet. 1970;130(3): 459-66.
51. Busuttil RW, Rinderbriecht H, Flesher A, Carmack C. Elastase activity: the role of elastase in aortic aneurysm formation. J Surg Res. 1982;32(3): 214-7.
52. Lindsay TF, Luo XP, Lehotay DC, Rubin BB, Anderson M, Walker PM, et al. Ruptured abdominal aortic aneurysm, a "two-hit" ischemia/reperfusion injury: evidence from an analysis of oxidative products. J Vasc Surg. 1999;30(2): 219-28.
53. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3): 273-9.
54. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Morishita R, Hashimoto N. Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Arterioscler Thromb Vasc Biol. 2009;29(7): 1080-6.
55. Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, et al. Genetic and pharmacologic disruption of interleukin-1 beta signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2013;33(2): 294-304.
56. Zhou HF, Yan H, Cannon JL, Springer LE, Green JM, Pham CT. CD43-mediated IFN-gamma production by CD8+ T cells promotes abdominal aortic aneurysm in mice. J Immunol. 2013;190(10): 5078-85.
57. Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T. Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension. 2009;54(6): 1337-44.
58. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke; J Cereb Circ. 1999;30(7): 1396-401.
59. Hansson GK. Immune and inflammatory mechanisms in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 1994;1 Suppl 1: S6-9.
60. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15(8): 1145-51.
61. Robson MC, Steed DL, Franz MG. Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg. 2001;38(2): 72-140.
62. Szycher M, Lee SJ. Modern wound dressings: a systematic approach to wound healing. J Biomater Appl. 1992;7(2): 142-213.
63. Richardson M. Acute wounds: an overview of the physiological healing process. Nurs Times. 2004;100(4): 50-3.
64. Nagata I, Handa H, Hasimoto N, Hazama F. Experimentally induced cerebral aneurysms in rats: VII. Scanning electron microscope study. Surg Neurol. 1981;16(4): 291-6.
65. Kojima M, Handa H, Hashimoto N, Kim C, Hazama F. Early changes of experimentally induced cerebral aneurysms in rats: scanning electron microscopic study. Stroke; J Cereb Circ. 1986;17(5): 835-41.
66. Kim C, Cervos-Navarro J, Kikuchi H, Hashimoto N, Hazama F. Alterations in cerebral vessels in experimental animals and their possible relationship to the development of aneurysms. Surg Neurol. 1992;38(5): 331-7.
67. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes Jr DR, Richardson DM, Ritman EL, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 2001;51(4): 762-6.
68. Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia-implications for vulnerable plaque-development. Atherosclerosis. 2007;192(2): 246-52.
69. Aoki T, Kataoka H, Moriwaki T, Nozaki K, Hashimoto N. Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke; J Cereb Circ. 2007;38(8): 2337-45.
70. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke; J Cereb Circ. 2007;38(1): 162-9.
71. Baker CJ, Fiore A, Connolly Jr ES, Baker KZ, Solomon RA. Serum elastase and alpha-1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysms. Neurosurgery. 1995;37(1): 56-61. discussion 61-52.
72. Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998;89(3): 431-40.
73. Kolega J, Gao L, Mandelbaum M, Mocco J, Siddiqui AH, Natarajan SK, et al. Cellular and molecular responses of the basilar terminus to hemodynamics during intracranial aneurysm initiation in a rabbit model. J Vasc Res. 2011;48(5): 429-42.
74. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol. 2000;20(12): E120-6.
75. Caird J, Napoli C, Taggart C, Farrell M, Bouchier-Hayes D. Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms. Eur J Neurol: Off J Eur Fed Neurol Soc. 2006;13(10): 1098-105.
76. Ishibashi R, Aoki T, Nishimura M, Miyamoto S. Imidapril inhibits cerebral aneurysm formation in an angiotensin-converting enzyme-independent and matrix metalloproteinase-9-dependent manner. Neurosurgery. 2012;70(3): 722-30.
77. Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Investig. 2008;118(9): 3012-24.
78. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke; J Cereb Circ. 2008;39(9): 2603-10.
79. Hosaka K, Downes DP, Nowicki KW, Hoh BL: modified murine intracranial aneurysm model: aneurysm formation and rupture by elastase and hypertension. Journal of NeuroInterventional Surgery 2013, In Press.
80. Kilic T, Sohrabifar M, Kurtkaya O, Yildirim O, Elmaci I, Gunel M, et al. Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery. 2005;57(5): 997-1007. discussion 1997-1007.
81. Tulamo R, Frosen J, Junnikkala S, Paetau A, Pitkaniemi J, Kangasniemi M, et al. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery. 2006;59(5): 1069-76. discussion 1076-1067.
82. Cai W, Devaux B, Schaper W, Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 1997;131(2): 177-86.
83. Mayr M, Xu Q. Smooth muscle cell apoptosis in arteriosclerosis. Exp Gerontol. 2001;36(7): 969-87.
84. Hansson GK. Cell-mediated immunity in atherosclerosis. Curr Opin Lipidol. 1997;8(5): 301-11.
85. Wajant H. The Fas signaling pathway: more than a paradigm. Science. 2002;296(5573): 1635-6.
86. Brune B, von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ. 1999;6(10): 969-75.
87. Takagi Y, Ishikawa M, Nozaki K, Yoshimura S, Hashimoto N. Increased expression of phosphorylated c-Jun amino-terminal kinase and phosphorylated c-Jun in human cerebral aneurysms: role of the c-Jun amino-terminal kinase/c-Jun pathway in apoptosis of vascular walls. Neurosurgery. 2002;51(4): 997-1002. discussion 1002-1004.
88. Valencia A, Morales H, Rivera R, Bravo E, Galvez M. Blood flow dynamics in patient-specific cerebral aneurysm models: the relationship between wall shear stress and aneurysm area index. Med Eng Phys. 2008;30(3): 329-40.
89. Rhoton Jr AL. Aneurysms. Neurosurgery. 2002;51(4 Suppl): S121-58.
90. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman LC, et al. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 2003;81(3): 177-99.
91. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res. 2004;95(5): 449-58.
92. Davies PF, Dewey Jr CF, Bussolari SR, Gordon EJ, Gimbrone Jr MA. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. J Clin Investig. 1984;73(4): 1121-9.
93. Davies PF, Mundel T, Barbee KA. A mechanism for heterogeneous endothelial responses to flow in vivo and in vitro. J Biomech. 1995;28(12): 1553-60.
94. Resnick N, Yahav H, Khachigian LM, Collins T, Anderson KR, Dewey FC, et al. Endothelial gene regulation by laminar shear stress. Adv Exp Med Biol. 1997;430: 155-64.
95. Davies PF, Shi C, Depaola N, Helmke BP, Polacek DC. Hemodynamics and the focal origin of atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. Ann N Y Acad Sci. 2001;947: 7-16. discussion 16-17.
96. Sun D, Huang A, Sharma S, Koller A, Kaley G. Endothelial microtubule disruption blocks flow-dependent dilation of arterioles. Am J Physiol Heart Circ Physiol. 2001;280(5): H2087-93.
97. Helmke BP, Davies PF. The cytoskeleton under external fluid mechanical forces: hemodynamic forces acting on the endothelium. Ann Biomed Eng. 2002;30(3): 284-96.
98. Conway D, Schwartz MA: Lessons from the endothelial junctional mechanosensory complex. F1000 biology reports 2012, 4: 1.
99. Tanoue T, Tateshima S, Villablanca JP, Vinuela F, Tanishita K. Wall shear stress distribution inside growing cerebral aneurysm. AJNR Am J Neuroradiol. 2011;32(9): 1732-7.
100. Kadirvel R, Ding YH, Dai D, Zakaria H, Robertson AM, Danielson MA, et al. The influence of hemodynamic forces on biomarkers in the walls of elastase-induced aneurysms in rabbits. Neuroradiology. 2007;49(12): 1041-53.
101. Gimbrone Jr MA, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci. 2000;902: 230-9. discussion 239-240.
102. Helmke BP, Goldman RD, Davies PF. Rapid displacement of vimentin intermediate filaments in living endothelial cells exposed to flow. Circ Res. 2000;86(7): 745-52.
103. Chen BP, Li YS, Zhao Y, Chen KD, Li S, Lao J, et al. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genom. 2001;7(1): 55-63.
104. Schnittler HJ, Schneider SW, Raifer H, Luo F, Dieterich P, Just I, et al. Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress. Pflugers Arch: Eur J Physiol. 2001;442(5): 675-87.
105. LaMack JA, Friedman MH. Individual and combined effects of shear stress magnitude and spatial gradient on endothelial cell gene expression. Am J Physiol Heart Circ Physiol. 2007;293(5): H2853-9.
106. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science. 1985;227(4693): 1477-9.
107. Khachigian LM, Resnick N, Gimbrone Jr MA, Collins T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Investig. 1995;96(2): 1169-75.
108. Nagel T, Resnick N, Dewey Jr CF, Gimbrone Jr MA. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb Vasc Biol. 1999;19(8): 1825-34.
109. Brooks AR, Lelkes PI, Rubanyi GM. Gene expression profiling of vascular endothelial cells exposed to fluid mechanical forces: relevance for focal susceptibility to atherosclerosis. Endothelium: J Endothel Cell Res. 2004;11(1): 45-57.
110. Passerini AG, Polacek DC, Shi C, Francesco NM, Manduchi E, Grant GR, et al. Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc Natl Acad Sci U S A. 2004;101(8): 2482-7.
111. Chiu JJ, Lee PL, Chen CN, Lee CI, Chang SF, Chen LJ, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24(1): 73-9.
112. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76(2): 168-75.
113. Cho A, Mitchell L, Koopmans D, Langille BL. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res. 1997;81(3): 328-37.
114. Chiu JJ, Chen LJ, Chen CN, Lee PL, Lee CI. A model for studying the effect of shear stress on interactions between vascular endothelial cells and smooth muscle cells. J Biomech. 2004;37(4): 531-9.
115. Hosaka K, Downes DP, Nowicki KW, Hoh BL: Modified murine intracranial aneurysm model: aneurysm formation and rupture by elastase and hypertension. Journal of neurointerventional surgery 2013.
116. Broughton G, 2nd, Janis JE, Attinger CE: Wound healing: an overview. Plast Reconstr Surg 2006, 117(7 Suppl): 1e-S-32e-S.
117. Vanwijck R: [Surgical biology of wound healing]. Bull Mem Acad R Med Belg 2001, 156(3-4): 175-184; discussion 185.
118. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A et al.: An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest, 121(3): 985-997.
119. Hoh BL, Velat GJ, Wilmer EN, Hosaka K, Fisher RC, Scott EW. A novel murine elastase saccular aneurysm model for studying bone marrow progenitor-derived cell-mediated processes in aneurysm formation. Neurosurgery. 2010;66(3): 544-50. discussion 550.
120. Hoh BL, Hosaka K, Downes DP, Nowicki KW, Fernandez CE, Batich CD, et al. Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1alpha and macrophage inflammatory protein-2-dependent pathway. Circulation. 2011;124(20): 2243-52.
121. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Investig. 1998;101(8): 1693-8.
122. Weber KS, Nelson PJ, Grone HJ, Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol. 1999;19(9): 2085-93.
123. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96(8): 881-9.
124. Liehn EA, Piccinini AM, Koenen RR, Soehnlein O, Adage T, Fatu R, et al. A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. J Am Coll Cardiol. 2010;56(22): 1847-57.
125. Mori E, Komori K, Yamaoka T, Tanii M, Kataoka C, Takeshita A, et al. Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation. 2002;105(24): 2905-10.